Exhibits
10-Q
from 10-Q 35 pages 10-Q
08/14/23
EX-10.2
from 10-Q 2 pages First Amendment to the Exclusive Sublicense Agreement
08/14/23
EX-10.3
from 10-Q 4 pages Second Amendment to the Exclusive Sublicense Agreement
08/14/23
EX-10.4
from 10-Q 20 pages Personal & Confidential Neil Fleshner 610 University Ave Suite 3-130, Toronto, on M5g 1z5 April 28, 2023 Dear Neil: On Behalf of POINT Biopharma (The “Company”), I Am Pleased to Offer You Regular Fulltime Employment as a Member of Our Team. Enclosed With This Letter Is an Employment Agreement That Sets Out the Details of the Company’s Offer. Please Carefully Review the Enclosed Agreement and Let Me Know if You Have Any Questions. if You Are Satisfied With the Terms and Conditions of Employment Set Out in the Enclosed Employment Agreement, Please Confirm Your Acceptance of the Company’s Offer by Signing and Dating the Agreement on the Last Page and Returning the Signed Copy to Jmccann@pointbiopharma.com No Later Than May 5, 2023, After Which, if Not Signed and Returned, This Offer Shall Be Automatically Withdrawn and It Shall Be Void. Yours Truly, POINT Biopharma Per: Joe McCann, CEO Enclosure: Employment Agreement Doc Id: 0e8c1064d1944de40d3f008216294afc40d1f371
08/14/23
EX-31.1
from 10-Q 2 pages Management certification of annual or quarterly disclosure
08/14/23
EX-31.2
from 10-Q 2 pages Management certification of annual or quarterly disclosure
08/14/23
EX-32
from 10-Q 1 page Management certification of financial report
08/14/23
Graphics & Data Files
External Links